Clinical determinants and prognostic significance of the electrocardiographic strain pattern in chronic kidney disease patients

Journal of the American Society of Hypertension

Volumn 8, Issue 5, 2014, Pages 312-320

  Cordeiro, Antonio C ^a   Moraes, Aline A I ^a   Cerutti, Virginia ^a   França, Faustino ^a   Quiroga, Borja ^b   Amodeo, Celso ^a   Picotti, Juliano C ^a   Dutra, Lucas V ^a   Rodrigues, Gabriel D ^a   Amparo, Fernanda C ^a   Lindholm, Bengt ^a,c   Carrero, Juan Jesús ^c  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Coronary artery disease; inflammation; myocardial ischemia; uremia

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHIC STRAIN; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOME ASSESSMENT; PATIENT RISK; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; BLOOD; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; EPIDEMIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PERIPHERAL VASCULAR DISEASES; PROGNOSIS;

AGED; ANTIHYPERTENSIVE AGENTS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; SMOKING; TROPONIN;

EID: 84901196527     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.02.011     Document Type: Article

References (40)

1. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 5 Suppl 3 1998 S112 S119
2. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, C.J. Martin, and D.C. Murray et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
3. A. Levin, J. Singer, C.R. Thompson, H. Ross, and M. Lewis Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention Am J Kidney Dis 27 1996 347 354
4. C. Zoccali, F.A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, and A. Cataliotti et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis J Am Soc Nephrol 12 2001 2768 2774
5. S.C. Chen, J.M. Chang, W.C. Liu, Y.Y. Chen, L.I. Chen, and J.C. Huang et al. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease Hypertens Res 35 2012 832 838
6. A.C. Cordeiro, B. Lindholm, M.G. Sousa, J.C. Picotti, G.J. Nunes, and M.R. Santana et al. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease J Hypertens 32 2014 439 445
7. S.J. Kim, H.J. Oh, D.E. Yoo, D.H. Shin, M.J. Lee, and H.R. Kim et al. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients PLoS One 7 2012 e35534
8. P.M. Okin, M.J. Roman, E.T. Lee, J.M. Galloway, B.V. Howard, and R.B. Devereux Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study Hypertension 43 2004 769 774
9. P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, R. Gattobigio, and I. Zampi et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension J Am Coll Cardiol 31 1998 383 390
10. B.P. Hsieh, M.X. Pham, and V.F. Froelicher Prognostic value of electrocardiographic criteria for left ventricular hypertrophy Am Heart J 150 2005 161 167
11. C.T. Larsen, J. Dahlin, H. Blackburn, H. Scharling, M. Appleyard, and B. Sigurd et al. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study Eur Heart J 23 2002 315 324
12. A.C. Cordeiro, A.R. Qureshi, B. Lindholm, F.C. Amparo, A. Tito-Paladino-Filho, and M. Perini et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease Nephrol Dial Transplant 28 Suppl 4 2013 iv152 iv159
13. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
14. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
17. M.J. Pencina, R.B. D'Agostino, K.M. Pencina, A.C. Janssens, and P. Greenland Interpreting incremental value of markers added to risk prediction models Am J Epidemiol 176 2012 473 481
18. G. Salles, C. Cardoso, A.R. Nogueira, K. Bloch, and E. Muxfeldt Importance of the electrocardiographic strain pattern in patients with resistant hypertension Hypertension 48 2006 437 442
19. P.M. Okin, R.B. Devereux, M.S. Nieminen, S. Jern, L. Oikarinen, and M. Viitasalo et al. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point J Am Coll Cardiol 38 2001 514 520
20. P.M. Okin, R.B. Devereux, M.S. Nieminen, S. Jern, L. Oikarinen, and M. Viitasalo et al. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients Hypertension 44 2004 48 54
21. P.M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S.E. Kjeldsen, and M.S. Nieminen et al. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) Circulation 119 2009 1883 1891
22. O.S. Ogah, A.A. Adebiyi, O.O. Oladapo, A. Aje, D.B. Ojji, and A.K. Adebayo et al. Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function Cardiology 106 2006 14 21
23. V. Palmieri, P.M. Okin, G. de Simone, J.N. Bella, K. Wachtell, and E. Gerdts et al. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study J Hypertens 25 2007 1079 1085
24. G. Schillaci, M. Pirro, L. Pasqualini, G. Vaudo, T. Ronti, and F. Gemelli et al. Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension J Hypertens 22 2004 407 414
25. W.B. Kannel Prevalence and natural history of electrocardiographic left ventricular hypertrophy Am J Med 75 1983 4 11
26. J.R. Payne, K.I. Eleftheriou, L.E. James, E. Hawe, J. Mann, and A. Stronge et al. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart Heart 92 2006 1784 1788
27. T. Otsuka, T. Kawada, Y. Seino, C. Ibuki, M. Katsumata, and E. Kodani Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease Am J Cardiol 106 2010 1456 1460
28. N. Kumar, M.F. Michelis, M.V. DeVita, G. Panagopoulos, and J.L. Rosenstock Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay Nephrol Dial Transplant 26 2011 665 670
29. R.K. Mishra, Y. Li, C. DeFilippi, M.J. Fischer, W. Yang, and M. Keane et al. Association of cardiac troponin T with left ventricular structure and function in CKD Am J Kidney Dis 61 2013 701 709
30. K.H. Yiu, C.T. Zhao, Y. Chen, C.W. Siu, Y.H. Chan, and K.K. Lau et al. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus Cardiovasc Diabetol 12 2013 94
31. J.O. Burton, H.J. Jefferies, N.M. Selby, and C.W. McIntyre Hemodialysis-induced cardiac injury: determinants and associated outcomes Clin J Am Soc Nephrol 4 2009 914 920
32. A.Y. Wang, and K.N. Lai Use of cardiac biomarkers in end-stage renal disease J Am Soc Nephrol 19 2008 1643 1652
33. I.A. Khan, J. Fink, C. Nass, H. Chen, R. Christenson, and C.R. deFilippi N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients Am J Cardiol 97 2006 1530 1534
34. Y. Arita, K. Hirata, N. Wada, K. Komukai, T. Tanimoto, and H. Kitabata et al. Altered coronary flow velocity reserve and left ventricular wall motion dynamics: a phenomenon in hypertensive patients with ECG strain Echocardiography 30 2013 634 643
35. S.D. Pringle, P.W. Macfarlane, J.H. McKillop, A.R. Lorimer, and F.G. Dunn Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension J Am Coll Cardiol 13 1989 1377 1381
36. H.V. Anderson, M.J. Stokes, M. Leon, S.A. Abu-Halawa, Y. Stuart, and R.L. Kirkeeide Coronary artery flow velocity is related to lumen area and regional left ventricular mass Circulation 102 2000 48 54
37. J.C. Rembert, L.H. Kleinman, J.M. Fedor, A.S. Wechsler, and J.C. Greenfield Jr. Myocardial blood flow distribution in concentric left ventricular hypertrophy J Clin Invest 62 1978 379 386
38. J.H. O'Keefe Jr., R.M. Owen, and A.A. Bove Influence of left ventricular mass on coronary artery cross-sectional area Am J Cardiol 59 1987 1395 1397
39. S.K. Mehta, J.E. Rame, A. Khera, S.A. Murphy, R.M. Canham, and R.M. Peshock et al. Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation Hypertension 49 2007 1385 1391
40. P.M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S.E. Kjeldsen, and M.S. Nieminen et al. Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study Eur J Heart Fail 13 2011 384 391